News & Publications
The latest news and publications about Merkel cell carcinoma and merkelcell.org.
Before 2016, patients with advanced Merkel cell carcinoma — a rare and extremely deadly skin cancer — had no good treatment options to extend their lives more than a few months. Then, with two pivotal trials, everything changed. On Monday, investigators presented new, long-term data from these t...
Read more →On February 16, 2018, UW Medicine released an article on the projected increase for cases of Merkel cell carcinoma in the United States. This rare, aggressive cancer is rising nearly six times faster than other cancers. Current studies show that the incidence is expected to exceed 3,025 cases by 202...
Read more →The University of Washington Newsletter recently published the story of Robert Yolles-- a husband whose ultimate goal was to help his wife, Monica, find the best possible doctors and treatments for her Merkel cell carcinoma. Through his search, he found Dr. Paul Nghiem. To this day, Yolles remains c...
Read more →Dear friends of Merkel cell carcinoma research, During this time of giving and celebrations, I want to let you know how appreciative our Merkel Team is of your support. This year was one of many exciting milestones that I am thrilled to share with you. We have written an annual update lette...
Read more →Authorization for BAVENCIO® (avelumab) as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (mMCC) has been granted in several locations worldwide. Updates on avelumab approvals: United States --- March 23, 2017 Switzerland --- September 5, 2017 E...
Read more →On October 27, 2017, Laura A. Stokowski, of Medscape, released the details from an interview with Dr. Paul Nghiem regarding Merkel cell carcinoma and its defining characteristics, proper management, and recent advances in treatment options. Use of the "AEIOU" characteristics can help in identifying...
Read more →On October 19th, 2017, Danielle Bucco of OncLive released an article pertaining to the advantages of treating Merkel cell carcinoma with immunotherapy. Historically, chemotherapy has been used as the first line of treatment. However, recent statistics highlight the difference in progression-free sur...
Read more →On Thursday October 19th, Dr. Paul Nghiem had the opportunity to meet with Dr. J. Helen Leonard. He shares his experience below. "After collaborating for over a decade, I, finally got to meet Dr J. Helen Leonard here in Brisbane, Australia, the city in which she started the world’s first resear...
Read more →On October 2, 2017, Jake Siegel, of The UW Medicine Huddle, released an article on Dr. Paul Nghiem's path to studying and specializing in Merkel cell carcinoma. As Nghiem states, "MCC had morphed from a chore to a moderately interesting subject to a two-decade whirlwind of clinical, basic and tr...
Read more →In recognition of Dr. Gregg Schimmel's support of hundreds of Merkel cell patients around the country, the Dr. Gregg Schimmel Fund for Merkel Cell Carcinoma Research Fellows has been established. To learn more about Gregg and make a donation, please visit: supportuwmedicine.org/gregg-schimmel R...
Read more →